173 related articles for article (PubMed ID: 10642342)
1. Mechanisms of increased venous smooth muscle tone in desoxycorticosterone acetate-salt hypertension.
Fink GD; Johnson RJ; Galligan JJ
Hypertension; 2000 Jan; 35(1 Pt 2):464-9. PubMed ID: 10642342
[TBL] [Abstract][Full Text] [Related]
2. Effect of an ET(B)-selective and a mixed ET(A/B) endothelin receptor antagonist on venomotor tone in deoxycorticosterone-salt hypertension.
Johnson RJ; Galligan JJ; Fink GD
J Hypertens; 2001 Mar; 19(3):431-40. PubMed ID: 11288813
[TBL] [Abstract][Full Text] [Related]
3. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
Matsumura Y; Hashimoto N; Taira S; Kuro T; Kitano R; Ohkita M; Opgenorth TJ; Takaoka M
Hypertension; 1999 Feb; 33(2):759-65. PubMed ID: 10024341
[TBL] [Abstract][Full Text] [Related]
4. Cardiac microvasculature in DOCA-salt hypertensive rats : effect of endothelin ET(A) receptor antagonism.
Larouche I; Schiffrin EL
Hypertension; 1999 Oct; 34(4 Pt 2):795-801. PubMed ID: 10523363
[TBL] [Abstract][Full Text] [Related]
5. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
Allcock GH; Venema RC; Pollock DM
Am J Physiol; 1998 Jul; 275(1):R245-52. PubMed ID: 9688985
[TBL] [Abstract][Full Text] [Related]
6. Central action of increased osmolality to support blood pressure in deoxycorticosterone acetate-salt rats.
O'Donaughy TL; Qi Y; Brooks VL
Hypertension; 2006 Oct; 48(4):658-63. PubMed ID: 16966581
[TBL] [Abstract][Full Text] [Related]
7. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
Li JS; Turgeon A; Schiffrin EL
Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists.
Watts SW; Fink GD; Northcott CA; Galligan JJ
Br J Pharmacol; 2002 Sep; 137(1):69-79. PubMed ID: 12183332
[TBL] [Abstract][Full Text] [Related]
9. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.
Giulumian AD; Pollock DM; Clarke N; Fuchs LC
Am J Physiol; 1998 Jun; 274(6):R1613-8. PubMed ID: 9608015
[TBL] [Abstract][Full Text] [Related]
10. Endothelin in the splanchnic vascular bed of DOCA-salt hypertensive rats.
Wang H; Chen AF; Watts SW; Galligan JJ; Fink GD
Am J Physiol Heart Circ Physiol; 2005 Feb; 288(2):H729-36. PubMed ID: 15471983
[TBL] [Abstract][Full Text] [Related]
11. Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension.
Carneiro FS; Nunes KP; Giachini FR; Lima VV; Carneiro ZN; Nogueira EF; Leite R; Ergul A; Rainey WE; Clinton Webb R; Tostes RC
J Sex Med; 2008 Dec; 5(12):2793-807. PubMed ID: 18823320
[TBL] [Abstract][Full Text] [Related]
12. Role of oxidative stress and nitric oxide in regulation of spontaneous tone in aorta of DOCA-salt hypertensive rats.
Ghosh M; Wang HD; McNeill JR
Br J Pharmacol; 2004 Feb; 141(4):562-73. PubMed ID: 14744820
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis in aorta of deoxycorticosterone acetate-salt hypertensive rats: effect of endothelin receptor antagonism.
Sharifi AM; Schiffrin EL
J Hypertens; 1997 Dec; 15(12 Pt 1):1441-8. PubMed ID: 9431850
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension.
Li L; Fink GD; Watts SW; Northcott CA; Galligan JJ; Pagano PJ; Chen AF
Circulation; 2003 Feb; 107(7):1053-8. PubMed ID: 12600921
[TBL] [Abstract][Full Text] [Related]
15. NADPH oxidase-derived superoxide augments endothelin-1-induced venoconstriction in mineralocorticoid hypertension.
Li L; Watts SW; Banes AK; Galligan JJ; Fink GD; Chen AF
Hypertension; 2003 Sep; 42(3):316-21. PubMed ID: 12885792
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of endothelin B receptors in kidneys of DOCA-salt hypertensive rats.
Pollock DM; Allcock GH; Krishnan A; Dayton BD; Pollock JS
Am J Physiol Renal Physiol; 2000 Feb; 278(2):F279-86. PubMed ID: 10662732
[TBL] [Abstract][Full Text] [Related]
17. Role of ET-1 receptor binding and [Ca(2+)](i) in contraction of coronary arteries from DOCA-salt hypertensive rats.
Giulumian AD; Molero MM; Reddy VB; Pollock JS; Pollock DM; Fuchs LC
Am J Physiol Heart Circ Physiol; 2002 May; 282(5):H1944-9. PubMed ID: 11959662
[TBL] [Abstract][Full Text] [Related]
18. ETA receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats.
Fujita K; Matsumura Y; Miyazaki Y; Hashimoto N; Takaoka M; Morimoto S
Life Sci; 1996; 58(1):PL1-7. PubMed ID: 8628104
[TBL] [Abstract][Full Text] [Related]
19. Myocardial fibrosis in DOCA-salt hypertensive rats: effect of endothelin ET(A) receptor antagonism.
Ammarguellat F; Larouche I; Schiffrin EL
Circulation; 2001 Jan; 103(2):319-24. PubMed ID: 11208696
[TBL] [Abstract][Full Text] [Related]
20. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
Schiffrin EL; Turgeon A; Deng LY
Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]